A still from the "Rromantasy" commercial (Organon) The ad ends with a final nod to the genre, with the claim that Nexplanon is “over 99% effective, no matter the fantasy.” Organon pledges $30M ...

Organon is down 6.7% during the same time and is heading into earnings with an average analyst price target of $18.67 (compared to the current share price of $13.19).

Organon (NYSE:OGN) is set to report its first-quarter 2025 earnings on Thursday, May 1st, before the market opens. Analysts expect the pharmaceutical company to earn $0.89 (-27.0% year-over-year ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported first-quarter net income of $87 million. The Jersey City, New Jersey-based company said it had net ...